Back
CorMedix, Inc. Stock Predictions
Exxon and Chevron Have an Unlikely New Competitor
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at
Sell
19
CRMD
CorMedix, Inc.
Last Price:
$7.01
Seasonality Move:
26.67%
7 Day Trial
ALL ACCESS PASS
$
7
The Next Gold Rush
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available atCorMedix, Inc. Stock Forecast
-
Over the next 52 weeks, CorMedix, Inc. has on average historically risen by 32.2% based on the past 15 years of stock performance.
-
CorMedix, Inc. has risen higher in 7 of those 15 years over the subsequent 52-week period, corresponding to a historical accuracy of 46.67%
-
Is CorMedix, Inc. Stock Undervalued?The current CorMedix, Inc. [CRMD] share price is $7.09. The Score for CRMD is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
-
CRMD is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
Will CorMedix, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, CorMedix, Inc. has on average historically risen by 32.2% based on the past 15 years of stock performance.
CorMedix, Inc. Stock Rating
Sell
19
CorMedix, Inc. (CRMD)
is a Sell
Is CorMedix, Inc. overpriced?
-
CorMedix, Inc. has risen higher in 7 of those 15 years over the subsequent 52-week period, corresponding to a historical accuracy of 46.67%
CorMedix, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
cormedix.com
52-Week Data
52-Week High:
17.43
52-Week Low:
5.60
Prediction Charts
Market Cap:
558.6M
Price in USD:
7.09
Volume:
3.5M
Beta:
1.38
Technical Analysis
SMA50:
10.69
SMA100:
11.35
SMA200:
11.22
52-Wk Change:
-36.81%
Stock Predictions
-
Is CorMedix, Inc. stock public?Yes, CorMedix, Inc. is a publicly traded company.
-
What is the CorMedix, Inc. stock quote today?The CorMedix, Inc. stock price is 7.09 USD today.
-
How to buy CorMedix, Inc. stock online?You can buy CorMedix, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-22 | 12.02 | 12.39 | 12.51 | 11.83 |
| Dec-24 | 12.09 | 12.19 | 12.24 | 12.00 |
| Dec-26 | 12.20 | 12.53 | 12.61 | 12.07 |
| Dec-29 | 12.50 | 12.73 | 12.82 | 12.36 |
| Dec-30 | 12.74 | 12.48 | 13.02 | 12.46 |
| Dec-31 | 12.40 | 11.63 | 12.45 | 11.62 |
| Jan-5 | 12.19 | 12.19 | 12.23 | 11.70 |
| Jan-6 | 12.29 | 11.26 | 12.29 | 11.19 |
| Jan-7 | 11.33 | 11.17 | 11.58 | 10.94 |
| Jan-8 | 8.74 | 7.51 | 9.41 | 7.22 |
| Jan-9 | 7.61 | 7.63 | 8.17 | 7.60 |
| Jan-12 | 7.58 | 7.15 | 7.59 | 7.01 |
| Jan-13 | 7.15 | 7.06 | 7.31 | 7.05 |
| Jan-14 | 7.05 | 7.09 | 7.44 | 7.04 |
CorMedix, Inc. Earnings
CorMedix, Inc. Earnings Report: Per Share CorMedix, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
CorMedix, Inc. Forecast Revenue Growth
CorMedix, Inc. Stock Analysis: Historical quarterly revenues per share for CorMedix, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.28 per share, and a decrease next year of $0.10 per share.
* CorMedix, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.